• Return to Headlines

Nektar Therapeut Has Returned 37.1% Since SmarTrend Recommendation (NKTR)

By Amy Schwartz

SmarTrend identified a Downtrend for Nektar Therapeut (NASDAQ:NKTR) on July 17th, 2019 at $32.33. In approximately 2 months, Nektar Therapeut has returned 37.08% as of today's recent price of $20.34.

In the past 52 weeks, Nektar Therapeut share prices have been bracketed by a low of $16.56 and a high of $66.95 and are now at $20.34, 23% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 4.9% while the 200-day MA has slid 1.2%.

Nektar Therapeutics, a research-based biopharmaceutical company, discovers and develops drug candidates for cancer, auto-immune disease, and chronic pain in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Nektar Therapeut.

Log in and add Nektar Therapeut (NKTR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights nektar therapeut

Ticker(s): NKTR